NF-kappaB as a potential molecular target for cancer therapy.
about
The ubiquitin-like protein FAT10 mediates NF-kappaB activationNew insights into the mechanisms of green tea catechins in the chemoprevention of prostate cancerInflammation in prostate cancer progression and therapeutic targetingUBXD Proteins: A Family of Proteins with Diverse Functions in CancerTranscription Factors in the Cellular Response to Charged Particle ExposureMyeloid differentiation primary response gene 88-leukotriene B4 receptor 2 cascade mediates lipopolysaccharide-potentiated invasiveness of breast cancer cellsIdentification of known drugs that act as inhibitors of NF-kappaB signaling and their mechanism of actionPulmonary oxidative stress, inflammation and cancer: respirable particulate matter, fibrous dusts and ozone as major causes of lung carcinogenesis through reactive oxygen species mechanismsTo NFκB or not to NFκB: The Dilemma on How to Inhibit a Cancer Cell Fate RegulatorFibromodulin suppresses nuclear factor-kappaB activity by inducing the delayed degradation of IKBA via a JNK-dependent pathway coupled to fibroblast apoptosisGadd45 proteins as critical signal transducers linking NF-kappaB to MAPK cascadesDirect observation of a transient ternary complex during IκBα-mediated dissociation of NF-κB from DNATherapeutic strategies for inhibiting invasion in glioblastoma.Anti-angiogenic effects of pterogynidine alkaloid isolated from Alchornea glandulosa.Virtual screening against p50 NF-kappaB transcription factor for the identification of inhibitors of the NF-kappaB-DNA interaction and expression of NF-kappaB upregulated genes.Anticancer activity of Nelumbo nucifera stamen extract in human colon cancer HCT-116 cells in vitro.NF-κB gene signature predicts prostate cancer progression.Recombinant fibromodulin and decorin effects on NF-κB and TGFβ1 in the 4T1 breast cancer cell line.Real-time monitoring of nuclear factor kappaB activity in cultured cells and in animal models.Potential malignant transformation in the gastric mucosa of immunodeficient mice with persistent Mycoplasma penetrans infection.NFkB is essential for activin-induced colorectal cancer migration via upregulation of PI3K-MDM2 pathway.Icotinib inhibits the invasion of Tca8113 cells via downregulation of nuclear factor κB-mediated matrix metalloproteinase expressionOverexpression of candidate tumor suppressor ECRG4 inhibits glioma proliferation and invasion.Hit identification of IKKβ natural product inhibitor.Activation of NF-kappa B signaling promotes growth of prostate cancer cells in bone.Genomics of the NF-κB signaling pathway: hypothesized role in ovarian cancer.Eugenol triggers apoptosis in breast cancer cells through E2F1/survivin down-regulation.Identifying novel glioma associated pathways based on systems biology level meta-analysisCylindroma transforming into basal cell carcinoma in a patient with Brooke-Spiegler syndromeGlaucine inhibits breast cancer cell migration and invasion by inhibiting MMP-9 gene expression through the suppression of NF-κB activation.CAPC negatively regulates NF-κB activation and suppresses tumor growth and metastasis.Different patterns of NF-κB and Notch1 signaling contribute to tumor-induced lymphangiogenesis of esophageal squamous cell carcinomaTumor cells and tumor-associated macrophages: secreted proteins as potential targets for therapy.Design, synthesis and biological evaluation of bivalent benzoxazolone and benzothiazolone ligands as potential anti-inflammatory/analgesic agents.Prognostic value of the expression of phosphatase and tensin homolog and CD44 in elderly patients with refractory acute myeloid leukemiaIncreased extracellular pressure stimulates tumor proliferation by a mechanosensitive calcium channel and PKC-β.Inactivation of ribosomal protein L22 promotes transformation by induction of the stemness factor, Lin28B.Imiquimod-induced apoptosis of melanoma cells is mediated by ER stress-dependent Noxa induction and enhanced by NF-κB inhibition.EGFRvIII promotes glioma angiogenesis and growth through the NF-κB, interleukin-8 pathwayThe pharmacological NF-κB inhibitor BAY11-7082 induces cell apoptosis and inhibits the migration of human uveal melanoma cells
P2860
Q24328851-BC355960-0F1E-4DCE-9573-AED94EA10283Q24619151-E43E66FE-324D-4414-BF83-82501D0C6FE2Q26773610-E238E8BF-D7BB-4A61-91C3-8BBB5AF71A73Q28069036-7474C763-437A-46AB-BE92-CC0A05C1332AQ28069717-5BE73062-246A-44C2-8AB2-6594D4F860D9Q28257239-CC8D16F1-00BF-427D-8B79-75D9B68A840FQ28270149-426B4294-478F-4FA3-BBB9-91A02326C525Q28297490-1D739BF9-D671-4FD2-902E-93C489C03B02Q28386593-D1797B74-18BA-446D-85C0-C3016462774CQ28386926-F4CAC267-0FF6-49EE-8335-2C02E7BFCD89Q28388105-208D38D4-35A0-4A34-A525-7ABBECB45C31Q33357416-C03B568C-56DF-454A-998A-A8C7609F939EQ33426563-E368971A-0827-432F-B49F-6053444DBF98Q33450973-C82244DC-73C1-4257-AAE2-9022824D8812Q33508859-C59D47D2-9B2C-4AFB-89BE-20B944A3DC47Q33598509-B115FF13-1FAF-4252-9928-94D010744555Q33624908-A22EC2AA-CFA7-4AFE-ABEF-75080656FA68Q33750977-01C6F69A-DADD-47F8-865E-D668ECC0EB1AQ33795121-C29BB4B5-3C4F-44FB-B1BA-DD83E0993390Q33888327-04C562BF-BAC2-4E98-8B15-58A1449B7D6CQ33913958-54F2935F-F0A8-4109-81B1-4FADD5EA6C42Q33967782-EFF9F9B0-D720-4225-9809-CFFE9FBBA1D1Q34036019-19E7E62F-98E5-42BA-AF65-3F645ADF3190Q34538026-68DB4648-383F-486B-9314-093E74087B71Q34664057-83FB9592-905D-4B37-9ED8-44A098BB573DQ35058278-F6A970A9-460C-4223-AB97-4C5944DB281CQ35065451-783A9B56-17F4-4443-B433-3A7CBBED58E8Q35102142-BABBAC23-F33D-4C0B-A288-B4C964FD41CFQ35169695-4E726DFF-FDD6-4675-A5D8-A9BE830492D3Q35252803-4E5C7934-762C-4741-A6A7-FAD154D09D09Q35541785-1E37DDBE-1B88-4A63-ABC8-51F0C72D5438Q35549652-6BB8FF78-0F28-40F6-887A-10B04871B1FEQ35582297-C8F817AF-BC38-4FE5-81E9-0D5EF18FE61FQ35742808-74DCBA99-D272-4595-9042-0238ED6FE027Q35803001-87809A7F-CD41-4628-A921-2C78CD6E7BB9Q35806374-720D0961-9E0E-4FD4-934E-D402DC94E81FQ36370851-53EEE828-56AC-46F2-8A4B-6E0FE8C2BF9EQ36504317-67039B92-9C8C-4ED4-8B62-30D54BB9B33AQ36510801-04A3F962-0A28-4EC2-95F7-2D8E8D8D4399Q36538277-084BF994-3FA7-40B3-B24A-89563B0D375B
P2860
NF-kappaB as a potential molecular target for cancer therapy.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
NF-kappaB as a potential molecular target for cancer therapy.
@en
type
label
NF-kappaB as a potential molecular target for cancer therapy.
@en
prefLabel
NF-kappaB as a potential molecular target for cancer therapy.
@en
P2093
P2860
P356
P1433
P1476
NF-kappaB as a potential molecular target for cancer therapy.
@en
P2093
Chae Hyeong Lee
Su-Hyeong Kim
Yong-Sang Song
Yong-Tark Jeon
P2860
P356
10.1002/BIOF.5520290103
P577
2007-01-01T00:00:00Z